Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, TX
Clinical Trial Details
Research Study Summary
Do You Have Moderate to Severe Rheumatoid Arthritis? Research Study RA0077
An international clinical research study is under way to evaluate and compare the safety and effectiveness of two approved drugs for people living with moderate to severe Rheumatoid Arthritis.
Qualified participants will receive study related medication and care at no cost. In order to participate in this study you must continue to take your Methotrexate as prescribed by your doctor. Other eligibility criteria will apply. You will receive compensation up to $50.00 per study visit.
To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.
Patient Inclusion Criteria:
If you have RA, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:
- Are a man or woman at least 18 years of age
- Have a confirmed diagnosis of Rheumatoid Arthritis, which is considered moderate to severe
Patient Exclusion Criteria:
- Currently not taking Methotrexate.
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these